XPS Pensions Group
XPS · Main Market · Financial Services · mcap £626m · 304.5p
- Market cap
- £618.2m
- Owner’s net cash
- −£45.4m
- Net cash / market cap
- -7%
- EV ex leases
- £663.6m
- Revenue
- £262.7m
- Operating profit
- £43.2m
- Free cash flow after leases
- £42.3m
- EV / EBIT
- 15.4×
- FCF yield
- 6.8%
- Price / tangible book
- 3.54×
- ROCE
- 16%
- Net income (owners)
- £26.6m
- Market cap
- £618.2m
- Cash
- £16.8m
- Borrowings
- £62.3m
- Net cash / (debt) ex leases
- −£45.4m
- Lease liabilities
- £15.8m
- Owner’s net cash
- −£45.4m
- Net cash / market cap
- -7%
- Cash − total liabilities
- −£137.8m
- Revenue
- £262.7m
- Operating profit
- £43.2m
- EBITDA (pre-IFRS 16)
- £56.7m
- Net income (owners)
- £26.6m
- Cash from operations
- £55.2m
- Free cash flow after leases
- £42.3m
- Cash conversion
- 208%
- EV ex leases
- £663.6m
- EV incl. leases
- £679.5m
- EV / EBIT
- 15.4×
- EV / EBITDA
- 11.7×
- FCF yield
- 6.8%
- Price / book
- 3.54×
- Tangible book
- £174.8m
- Price / tangible book
- 3.54×
- NCAV (net current asset value)
- −£66.6m
- Price / NCAV
- –
- Net-net working capital
- −£85.0m
- ROCE
- 16%
- ROE
- 15%
- Current ratio
- 1.61×
- Net debt / EBITDA
- 0.8×
- Accruals ratio
- -8.7%
- Revenue
- £129m +13%
- Operating profit
- £15.8m −19%
- Net income
- £8.6m −34%
- Cash from operations
- £15.5m −17%
Hover or tap a figure for its formula and the values used – the names are the line names of the key figures below. Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
The statement exactly as printed in one results announcement – its own columns (the period and its comparatives), lines and headings, in the company's currency and units. Choose the report above; to compare several years, use Key figures.
Standardised line items in £m, comparable across companies; when a later report restated a period, the later figure is shown and marked r (hover for the figure first reported). Italic = calculated (LTM, H2 = FY − H1); a year of other than 12 months is marked (15m). Hover a value for its source.
Latest report: FY Mar 26 (twelve months to 31 Mar 26), published 18 Jun 26 · read the results ↗
| 2026 Trading items £'000 | 2026 Non-trading and exceptional items 1 £'000 | 2026 Total £'000 | 2025 Trading items £'000 | 2025 Non-trading and exceptional items 1 £'000 | 2025 Total £'000 | |
|---|---|---|---|---|---|---|
| Revenue | 262,659 | - | 262,659 | 231,785 | - | 231,785 |
| Other operating (expense)/income | - | (110) | (110) | - | 988 | 988 |
| Operating expenses | (193,992) | (25,327) | (219,319) | (168,888) | (19,703) | (188,591) |
| Profit/(loss) from operating activities | 68,667 | (25,437) | 43,230 | 62,897 | (18,715) | 44,182 |
| Finance income | 91 | - | 91 | 109 | - | 109 |
| Finance costs | (4,607) | - | (4,607) | (3,541) | - | (3,541) |
| Profit/(loss) before tax | 64,151 | (25,437) | 38,714 | 59,465 | (18,715) | 40,750 |
| Income tax (expense)/credit | (16,214) | 4,058 | (12,156) | (14,353) | 3,946 | (10,407) |
| Profit/(loss) after tax and total comprehensive income/(loss) for the year | 47,937 | (21,379) | 26,558 | 45,112 | (14,769) | 30,343 |
| Pence Pence Pence Pence | ||||||
| Profit or loss | ||||||
| Basic earnings per share | 23.5 | - | 13.0 | 21.9 | - | 14.7 |
| Diluted earnings per share | 22.3 | - | 12.4 | 20.6 | - | 13.8 |
| 2026 £'000 | 2025 £'000 | |
|---|---|---|
| Assets | ||
| Non-current assets | ||
| Property, plant and equipment | 5,889 | 5,278 |
| Right-of-use assets | 14,373 | 13,835 |
| Intangible assets | 218,247 | 222,998 |
| Other long-term receivables | 2,985 | 5,971 |
| Total non-current assets | 241,494 | 248,082 |
| Current assets | ||
| Trade and other receivables | 70,432 | 60,683 |
| Current income tax asset | 714 | - |
| Cash and cash equivalents | 16,848 | 14,717 |
| Total current assets | 87,994 | 75,400 |
| Total assets | 329,488 | 323,482 |
| Liabilities | ||
| Non-current liabilities | ||
| Loans and borrowings | 62,251 | 54,021 |
| Lease liabilities | 12,473 | 12,038 |
| Provisions | 2,717 | 2,903 |
| Trade and other payables | 5,488 | 670 |
| Deferred tax liabilities | 17,070 | 16,138 |
| Total non-current liabilities | 99,999 | 85,770 |
| Current liabilities | ||
| Lease liabilities | 3,353 | 2,915 |
| Provisions | 3,728 | 2,700 |
| Trade and other payables | 47,561 | 46,456 |
| Current income tax liabilities | - | 234 |
| Total current liabilities | 54,642 | 52,305 |
| Total liabilities | 154,641 | 138,075 |
| Net assets | 174,847 | 185,407 |
| Equity | ||
| Equity attributable to owners of the parent | ||
| Share capital | 104 | 104 |
| Share premium | 1,786 | 1,786 |
| Merger relief reserve | 48,687 | 48,687 |
| Investment in own shares held in trust | (18,233) | (15,142) |
| Retained earnings | 142,503 | 149,972 |
| Total equity | 174,847 | 185,407 |
| 2026 £'000 | 2025 £'000 | |
|---|---|---|
| Cash flows from operating activities | ||
| Profit for the year | 26,558 | 30,343 |
| Adjustments for | ||
| Depreciation | 1,234 | 1,034 |
| Depreciation of right-of-use assets | 2,986 | 2,962 |
| Amortisation | 12,246 | 9,832 |
| Finance income | (91) | (109) |
| Finance costs | 4,607 | 3,541 |
| Gain on acquisition of business | - | (988) |
| Fair value loss on consideration paid | 110 | - |
| Share-based payment expense | 7,025 | 5,946 |
| Income tax expense | 12,156 | 10,407 |
| Total adjustments for | 66,831 | 62,968 |
| Increase in trade and other receivables | (6,763) | (13,509) |
| Increase in trade and other payables | 5,713 | 2,060 |
| Increase in provisions | 405 | 1,449 |
| 66,186 | 52,968 | |
| Income tax paid | (10,970) | (11,152) |
| Net cash inflow from operating activities | 55,216 | 41,816 |
| Cash flows from investing activities | ||
| Finance income received | 91 | 109 |
| Acquisition of subsidiary, net of cash acquired | - | (13,774) |
| Purchases of property, plant and equipment | (2,149) | (2,101) |
| Purchases of intangibles | (7,827) | (6,089) |
| Net cash outflow from investing activities | (9,885) | (21,855) |
| Cash flows from financing activities | ||
| Proceeds from existing loans | 18,000 | 39,333 |
| Repayment of loans | (10,000) | (9,000) |
| Payment relating to extension of loan facility | - | (332) |
| Proceeds from the exercise of share options settled by EBT shares | 2,275 | 868 |
| Purchase of own shares by EBT | (20,914) | (18,715) |
| Interest paid | (3,710) | (2,312) |
| Lease interest paid | (666) | (318) |
| Payment of lease liabilities | (2,255) | (1,997) |
| Dividends paid to the holders of the parent | (25,047) | (22,185) |
| Dividend equivalents paid on vesting of share options | (883) | (591) |
| Net cash outflow from financing activities | (43,200) | (15,249) |
| Net increase in cash and cash equivalents | 2,131 | 4,712 |
| Cash and cash equivalents at start of year | 14,717 | 10,005 |
| Cash and cash equivalents at end of year | 16,848 | 14,717 |
| 2025 Trading items Unaudited £'000 | 2025 Non-trading and exceptional items 1 Unaudited £'000 | 2025 Total Unaudited £'000 | 2024 Trading items Unaudited £'000 | 2024 Non-trading and exceptional items 1 Unaudited £'000 | 2024 Total Unaudited £'000 | |
|---|---|---|---|---|---|---|
| Revenue | 128,526 | - | 128,526 | 113,414 | - | 113,414 |
| Operating expenses | (98,545) | (14,205) | (112,750) | (85,590) | (8,232) | (93,822) |
| Profit/(loss) from operating activities | 29,981 | (14,205) | 15,776 | 27,824 | (8,232) | 19,592 |
| Finance income | 52 | - | 52 | 36 | - | 36 |
| Finance costs | (2,165) | - | (2,165) | (1,383) | - | (1,383) |
| Profit/(loss) before tax | 27,868 | (14,205) | 13,663 | 26,477 | (8,232) | 18,245 |
| Income tax (expense)/credit | (7,003) | 1,981 | (5,022) | (6,973) | 1,766 | (5,207) |
| Profit/(loss) after tax and total comprehensive income for the period | 20,865 | (12,224) | 8,641 | 19,504 | (6,466) | 13,038 |
| Pence Pence Pence Pence | ||||||
| Profit or loss | ||||||
| Basic earnings per share | 10.2 | 4.2 | 9.4 | 6.3 | – | – |
| Diluted earnings per share | 9.7 | 4.0 | 8.9 | 5.9 | – | – |
| 30 September 2025 Unaudited £'000 | 31 March 2025 Audited £'000 | |
|---|---|---|
| Assets | ||
| Non-current assets | ||
| Property, plant and equipment | 5,356 | 5,278 |
| Right-of-use assets | 15,649 | 13,835 |
| Intangible assets | 220,170 | 222,998 |
| Other long-term receivables | 4,479 | 5,971 |
| Total non-current assets | 245,654 | 248,082 |
| Current assets | ||
| Trade and other receivables | 63,312 | 60,683 |
| Current income tax asset | 1,734 | - |
| Cash and cash equivalents | 10,843 | 14,717 |
| Total current assets | 75,889 | 75,400 |
| Total assets | 321,543 | 323,482 |
| Liabilities | ||
| Non-current liabilities | ||
| Loans and borrowings | 72,126 | 54,021 |
| Lease liabilities | 13,596 | 12,038 |
| Provisions | 2,433 | 2,903 |
| Trade and other payables | 4,435 | 670 |
| Deferred tax liabilities | 17,791 | 16,138 |
| Total non-current liabilities | 110,381 | 85,770 |
| Current liabilities | ||
| Lease liabilities | 3,473 | 2,915 |
| Provisions | 3,128 | 2,700 |
| Trade and other payables | 36,332 | 46,456 |
| Current income tax liabilities | - | 234 |
| Total current liabilities | 42,933 | 52,305 |
| Total liabilities | 153,314 | 138,075 |
| Net assets | 168,229 | 185,407 |
| Equity | ||
| Equity attributable to owners of the parent | ||
| Share capital | 104 | 104 |
| Share premium | 1,786 | 1,786 |
| Merger relief reserve | 48,687 | 48,687 |
| Investment in own shares held in trust | (13,374) | (15,142) |
| Retained earnings | 131,026 | 149,972 |
| Total equity | 168,229 | 185,407 |
| 2025 Unaudited £'000 | 2024 Unaudited £'000 | |
|---|---|---|
| Cash flows from operating activities | ||
| Profit after tax for the period | 8,641 | 13,038 |
| Adjustments for | ||
| Depreciation | 581 | 486 |
| Depreciation of right-of-use assets | 1,415 | 1,390 |
| Amortisation | 6,181 | 4,621 |
| Finance income | (52) | (36) |
| Finance costs | 2,165 | 1,383 |
| Share-based payment expense | 3,461 | 2,586 |
| Income tax expense | 5,022 | 5,207 |
| Total adjustments for | 27,414 | 28,675 |
| Increase in trade and other receivables | (1,137) | (2,287) |
| Decrease in trade and other payables | (5,485) | (1,683) |
| (Decrease)/increase in provisions | (383) | 122 |
| 20,409 | 24,827 | |
| Income tax paid | (4,912) | (6,068) |
| Net cash inflow from operating activities | 15,497 | 18,759 |
| Cash flows from investing activities | ||
| Purchases of property, plant and equipment | (735) | (1,603) |
| Purchases of software | (3,688) | (2,779) |
| Net cash outflow from investing activities | (4,423) | (4,382) |
| Cash flows from financing activities | ||
| Proceeds from existing loans | 18,000 | 12,000 |
| Repayment of loans | - | (4,000) |
| Payment relating to extension of loan facility | (20) | - |
| Purchase of own shares | (14,485) | (6,405) |
| Proceeds from the exercise of share options settled by EBT shares | 1,899 | 767 |
| Interest paid | (1,660) | (870) |
| Lease interest paid | (207) | (166) |
| Payment of lease liabilities | (902) | (966) |
| Dividends paid to the holders of the parent | (16,697) | (14,577) |
| Dividend equivalents paid on vesting of share options | (876) | (591) |
| Net cash outflow from financing activities | (14,948) | (14,808) |
| Net decrease in cash and cash equivalents | (3,874) | (431) |
| Cash and cash equivalents at start of the period | 14,717 | 10,005 |
| Cash and cash equivalents at end of period | 10,843 | 9,574 |
| FY Mar 26 | FY Mar 25 | |
|---|---|---|
| Revenue to operating profit | ||
| Revenue | 262.7 | 231.8 |
| Adjusted EBITDA | 75.7 | 69.7 |
| EBITDA | 59.7 | 58.0 |
| Adjusted operating profit | 68.7 | 62.9 |
| Exceptional / adjusting items | (25.4) | (18.7) |
| Operating profit | 43.2 | 44.2 |
| Depreciation (owned assets) | 1.2 | 1.0 |
| Depreciation (right-of-use) | 3.0 | 3.0 |
| Amortisation | 12.2 | 9.8 |
| Share-based payments | 7.0 | 5.9 |
| Operating profit to net income | ||
| Finance costs | (4.6) | (3.5) |
| Profit before tax | 38.7 | 40.8 |
| Tax | (12.2) | (10.4) |
| Net income (owners) | 26.6 | 30.3 |
| Per share | ||
| EPS basic | 13.0p | 14.7p |
| EPS diluted | 12.4p | 13.8p |
| Dividend per share | 13.2p | 11.9p |
| H2 Mar 26 | H1 Sep 25 | H2 Mar 25 | H1 Sep 24 | |
|---|---|---|---|---|
| Revenue to operating profit | ||||
| Revenue | 134.1 | 128.5 | 118.4 | 113.4 |
| Adjusted EBITDA | 42.2 | 33.4 | 38.8 | 30.9 |
| EBITDA | 35.7 | 24.0 | 31.9 | 26.1 |
| Adjusted operating profit | 38.7 | 30.0 | 35.1 | 27.8 |
| Operating profit | 27.5 | 15.8 | 24.6 | 19.6 |
| Depreciation (owned assets) | 0.7 | 0.6 | 0.5 | 0.5 |
| Depreciation (right-of-use) | 1.6 | 1.4 | 1.6 | 1.4 |
| Amortisation | 6.1 | 6.2 | 5.2 | 4.6 |
| Share-based payments | 3.6 | 3.5 | 3.4 | 2.6 |
| Operating profit to net income | ||||
| Finance costs | (2.4) | (2.2) | (2.2) | (1.4) |
| Profit before tax | 25.1 | 13.7 | 22.5 | 18.2 |
| Tax | (7.1) | (5.0) | (5.2) | (5.2) |
| Net income (owners) | 17.9 | 8.6 | 17.3 | 13.0 |
| Per share | ||||
| EPS basic | 8.8p | 4.2p | 8.4p | 6.3p |
| EPS diluted | 8.4p | 4.0p | 7.9p | 5.9p |
| Dividend per share | 9.1p | 4.1p | 8.2p | 3.7p |
| FY Mar 26 | FY Mar 25 | |
|---|---|---|
| Operating activities | ||
| Cash from operations | 55.2 | 41.8 |
| Interest paid | (3.7) | (2.3) |
| Tax paid | (11.0) | (11.2) |
| Investing activities | ||
| Capex (PP&E) | (2.1) | (2.1) |
| Capex (intangibles) | (7.8) | (6.1) |
| Financing activities | ||
| Lease principal paid | (2.3) | (2.0) |
| Lease interest paid | (0.7) | (0.3) |
| Dividends paid | (25.0) | (22.2) |
| Share buybacks | (20.9) | (18.7) |
| Shares issued | 2.3 | 0.9 |
| H2 Mar 26 | H1 Sep 25 | H2 Mar 25 | H1 Sep 24 | |
|---|---|---|---|---|
| Operating activities | ||||
| Cash from operations | 39.7 | 15.5 | 23.1 | 18.8 |
| Interest paid | (2.0) | (1.7) | (1.4) | (0.9) |
| Tax paid | (6.1) | (4.9) | (5.1) | (6.1) |
| Investing activities | ||||
| Capex (PP&E) | (1.4) | (0.7) | (0.5) | (1.6) |
| Capex (intangibles) | (4.1) | (3.7) | (3.3) | (2.8) |
| Financing activities | ||||
| Lease principal paid | (1.4) | (0.9) | (1.0) | (1.0) |
| Lease interest paid | (0.5) | (0.2) | (0.2) | (0.2) |
| Dividends paid | (8.3) | (16.7) | (7.6) | (14.6) |
| Share buybacks | (6.4) | (14.5) | (12.3) | (6.4) |
| 31 Mar 26 | 31 Mar 25 | |
|---|---|---|
| Non-current assets | ||
| Other intangibles | – | 223.0 |
| Property, plant & equipment | 5.9 | 5.3 |
| Non-current assets | 241.5 | 248.1 |
| Current assets | ||
| Trade receivables | 70.4 | 60.7 |
| Cash | 16.8 | 14.7 |
| Current assets | 88.0 | 75.4 |
| Total assets | 329.5 | 323.5 |
| Current liabilities | ||
| Trade payables | 47.6 | 46.5 |
| Lease liabilities, current | 3.4 | 2.9 |
| Current liabilities | 54.6 | 52.3 |
| Non-current liabilities | ||
| Borrowings, non-current | 62.3 | 54.0 |
| Lease liabilities, non-current | 12.5 | 12.0 |
| Non-current liabilities | 100.0 | 85.8 |
| Total liabilities | 154.6 | 138.1 |
| Equity | ||
| Total equity | 174.8 | 185.4 |
| Net cash and other figures | ||
| Net cash / (debt) ex leases | (46.2) | (40.3) |
| 31 Mar 26 | 30 Sep 25 | 31 Mar 25 | 30 Sep 24 | |
|---|---|---|---|---|
| Non-current assets | ||||
| Other intangibles | – | 220.2 | 223.0 | – |
| Property, plant & equipment | 5.9 | 5.4 | 5.3 | – |
| Non-current assets | 241.5 | 245.7 | 248.1 | – |
| Current assets | ||||
| Trade receivables | 70.4 | 63.3 | 60.7 | – |
| Cash | 16.8 | 10.8 | 14.7 | – |
| Current assets | 88.0 | 75.9 | 75.4 | – |
| Total assets | 329.5 | 321.5 | 323.5 | – |
| Current liabilities | ||||
| Trade payables | 47.6 | 36.3 | 46.5 | – |
| Lease liabilities, current | 3.4 | 3.5 | 2.9 | – |
| Current liabilities | 54.6 | 42.9 | 52.3 | – |
| Non-current liabilities | ||||
| Borrowings, non-current | 62.3 | 72.1 | 54.0 | – |
| Lease liabilities, non-current | 12.5 | 13.6 | 12.0 | – |
| Non-current liabilities | 100.0 | 110.4 | 85.8 | – |
| Total liabilities | 154.6 | 153.3 | 138.1 | – |
| Equity | ||||
| Total equity | 174.8 | 168.2 | 185.4 | – |
| Net cash and other figures | ||||
| Net cash / (debt) ex leases | (46.2) | (62.2) | (40.3) | (22.4) |
| Undrawn facilities | – | 47.0 | – | – |
Read automatically from each results announcement. Check the source before relying on a figure.
Spotted an error in this income statement? Report it
Company filings. Not investment advice.